MedCity News March 18, 2024
Frank Vinluan

Generic drugs are the pharmaceutical products mainly affected by the missile attacks disrupting shipping in the Red Sea. While the extra costs borne by drug companies aren’t causing an immediate spike in product prices, experts say they’ll eventually be factored into prices if the attacks become a long-term problem.

When a patient fills a prescription at a pharmacy close to home, the transaction is the last part of a tightly controlled supply chain that starts on the other side of the world. In recent months, a crucial part of that chain has been strained. The Iran-backed Houthi militia group continues to rain down missiles on container ships traversing the Red Sea, disrupting or diverting the movement of goods that in...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Supply Chain, Technology
How Pharmacy Deserts, Biosimilars, and Market Trends Are Shaping Managed Care
CVS Caremark taps Omada on GLP-1 program
23andMe is potentially selling more than just genetic data. Survey info is just as much a privacy problem
InnovationRx: Trump Administration Health Agency Layoffs Threaten Biotech Innovation
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?

Share This Article